Form EFFECT Moleculin Biotech, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 9, 2024 |
| Accession Number: | 0001437749-24-036590 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moleculin reports 37% blinded remission rate in AML trial interim data
- BCAS Calls for National Commission on the Legacy of Slavery and Anti-Black Racism in Canada
- Bitcoin Price Prediction: BTC Slides Below $63K as AlphaPepe Gives Dip Buyers a Pre-Chart Alternative to Waiting for Recovery
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
